Urology Pharmaceutical Company - India

Urology

SPECIALTY SEGMENT

Urology

Urology is the branch of medicine focused on the urinary tract system — kidneys, ureters, bladder and urethra — as well as the male reproductive system. Urological conditions range from urinary tract infections and kidney stones to benign prostatic hyperplasia (BPH), gout and overactive bladder.

In India, urological disorders are increasingly common — yet many go undiagnosed or undertreated due to stigma, low awareness and limited access to specialist care. Benign prostatic hyperplasia alone affects nearly 50% of Indian men over 50. Gout prevalence is rising rapidly with changing diets and lifestyle patterns.

At Quinek Life Sciences, our Urology segment provides specialists with a targeted range of WHO-GMP certified medicines — from alpha blockers and combination BPH therapies to gout management, UTI treatment and overactive bladder care.

50% of Men

Over 50 affected by BPH in India

40% Rise

In gout cases in India over last decade

10 Products

Across 5 urology categories

THE REALITY

Urological Health in India — The Numbers

50%

Men Over 50 Have BPH

Most common urological condition in Indian men

40%

Rise in Gout Cases

Driven by diet and lifestyle changes in India

150M+

UTI Cases Annually

Primarily affecting women and elderly men

30%

Overactive Bladder

Nearly 1 in 3 adults over 40 affected

WHY WE BUILT THIS SEGMENT

BPH Cases in India — Rising with an Ageing Population

As India’s population ages, the burden of benign prostatic hyperplasia is growing rapidly. Early treatment with quality alpha blockers and combination therapies is essential to prevent progression.

Reported BPH Cases (millions)
Projected if unaddressed

35M

2019

40M

2020

45M

2021

50M

2022

55M

2023

60M